Clinical Trials Directory

Trials / Completed

CompletedNCT01691404

Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)

Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure in Untreated (Pre)Hypertensive Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Wageningen University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

Flavonoid-rich foods such as tea and cocoa have been identified as having a blood pressure-lowering effect. Part of this effect is thought to be due to the flavonoid content of these foods although it is currently unknown which flavonoids play a role. Epicatechin is one the major flavonoids in cocoa while quercetin is largely found in tea. During this study the investigators plan to investigate the effects of pure epicatechin and quercetin supplementation on vascular function and blood pressure in untreated (prehypertensive) subjects by way of a three-armed double-blind crossover intervention. Participants will sequentially consume supplements containing quercetin, epicatechin or placebo for a period of 4 weeks. Before and after this 4 week period, measurements of vascular function and blood pressure will be taken. The investigators hypothesize that the supplementation of epicatechin and quercetin will improve vascular function and blood pressure.

Detailed description

By means of a three-armed double-blind crossover intervention, the effects of pure flavonoid supplementation will be investigated. The products under investigation will be epicatechin and quercetin-3-glucoside. Subjects will be asked to consume either 160mg of quercetin-3-glucoside, 100mg of epicatechin or a placebo capsule for a period of 4 weeks. Measurements of vascular function and blood pressure will be taken before and after each 4-week intervention period. A 4-week washout period will be planned between each intervention. Measurements of vascular function will include flow-mediated dilation, pulse wave analysis, pulse wave velocity and vasomotion as well as biomarkers of inflammation and vascular function.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEpicatechinSubjects will be asked to consume supplements containing 100mg of epicatechin daily
DIETARY_SUPPLEMENTQuercetinSubjects will be asked to consume 160mg of quercetin-3-glucoside daily
DIETARY_SUPPLEMENTPlaceboSubjects will be asked to consume capsules containing placebo (cellulose) daily

Timeline

Start date
2012-09-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-09-24
Last updated
2013-04-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01691404. Inclusion in this directory is not an endorsement.